| Mrs Lorrie Jill Hudson, MSW, LICSW | |
|
Rr 2 Box 355k, Fayetteville, WV 25840-9586 | |
| (304) 574-1585 | |
| Not Available |
| Full Name | Mrs Lorrie Jill Hudson |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | Rr 2 Box 355k, Fayetteville, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174774772 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | DP03943081 (West Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Lorrie Jill Hudson, MSW, LICSW Rr 2 Box 355k, Fayetteville, WV 25840-9586 Ph: (304) 574-1585 | Mrs Lorrie Jill Hudson, MSW, LICSW Rr 2 Box 355k, Fayetteville, WV 25840-9586 Ph: (304) 574-1585 |
News Archive
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused more than 3.42 million deaths worldwide. Despite the fact that there are vaccines for SARS-CoV-2, the emergence of new variants and the lack of adequate treatments have encouraged the search for new ways to combat this disease more effectively.
Trim Holding Group ("the Company") announced that on December 31, 2009 the Company purchased patent rights under a patent agreement signed with Allkey Ltd. In consideration of the patent rights, the Company issued 3,750,000 preferred shares with a par value of $7.00/share.
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
Scientists are working to understand the mechanisms that make weight loss so complicated. Exercise burns calories, of course, but scientists are also looking at how the body burns more energy to stay warm in cold temperatures.
Oncolytics Biotech Inc. announced today that the Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, U.S. National Cancer Institute (NCI), which is part of the National Institutes of Health, has agreed to sponsor a 2-Arm randomized Phase II study of carboplatin, paclitaxel plus REOLYSIN® versus carboplatin and paclitaxel alone in the first line treatment of patients with recurrent or metastatic pancreatic cancer.
› Verified 4 days ago
Joann Inglut Tweeddale, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 100 2nd Ave, Fayetteville, WV 25840 Phone: 304-573-1523 | |
Heather Renee Collins, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 209 W Maple Ave, Fayetteville, WV 25840 Phone: 304-574-2100 | |
Mark Vincent Sundstrom, M.S.,LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 209 W Maple Ave, Fayetteville, WV 25840 Phone: 304-574-2100 Fax: 304-574-2151 | |
Chelsey Nicole Keathley, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 351 New River Ranch Dr, Fayetteville, WV 25840 Phone: 304-574-1058 |